What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His primary areas of study are Internal medicine, Adenosine receptor, Endocrinology, Adenosine and Risk factor.
As a member of one scientific family, Michael A. Schwarzschild mostly works in the field of Internal medicine, focusing on Surgery and, on occasion, Confidence interval, Uric acid and Gastroenterology.
His studies deal with areas such as Signal transduction and Phosphorylation as well as Endocrinology.
He has included themes like Adenosine A3 receptor, Receptor, Adenosine A2A receptor, Neuroscience and Pharmacology in his Adenosine study.
The study incorporates disciplines such as Relative risk, Central nervous system disease and Cohort in addition to Risk factor.
Parkinson's disease is a subfield of Disease that Michael A. Schwarzschild investigates.
His most cited work include:
- The epidemiology of Parkinson's disease: risk factors and prevention (527 citations)
- Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease (519 citations)
- A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice (491 citations)
What are the main themes of his work throughout his whole career to date?
Michael A. Schwarzschild spends much of his time researching Internal medicine, Parkinson's disease, Disease, Endocrinology and Pharmacology.
His study involves Confidence interval, Prospective cohort study, Relative risk, Risk factor and Cohort, a branch of Internal medicine.
His Prospective cohort study study incorporates themes from Physical therapy and Cohort study.
His Parkinson's disease study combines topics in areas such as Biomarker, Dopamine and Parkinsonism.
The Disease study combines topics in areas such as Clinical trial, Bioinformatics, Central nervous system disease, Epidemiology and Oncology.
His Pharmacology study integrates concerns from other disciplines, such as Adenosine A2A receptor, Adenosine receptor, Adenosine and Caffeine.
He most often published in these fields:
- Internal medicine (48.61%)
- Parkinson's disease (31.47%)
- Disease (30.28%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (48.61%)
- Disease (30.28%)
- Parkinson's disease (31.47%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Disease, Parkinson's disease, Cohort and Clinical trial.
His biological study spans a wide range of topics, including Gastroenterology and Oncology.
His Disease research is multidisciplinary, relying on both Lower risk, Cohort study, Family history and Genetic testing.
Michael A. Schwarzschild has researched Parkinson's disease in several fields, including Disease progression, Epidemiology, Gerontology, Caffeine and Neuroprotection.
His work carried out in the field of Caffeine brings together such families of science as Relative risk, Metabolomics, GRIN2A, LRRK2 and Pharmacology.
The various areas that Michael A. Schwarzschild examines in his Cohort study include Body mass index and Fasting Status.
Between 2017 and 2021, his most popular works were:
- Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. (79 citations)
- Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? (28 citations)
- Higher urate in LRRK2 mutation carriers resistant to Parkinson disease (21 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Michael A. Schwarzschild mainly focuses on Internal medicine, Disease, Parkinson's disease, Confidence interval and Amyotrophic lateral sclerosis.
His study connects Gastroenterology and Internal medicine.
His Disease research incorporates elements of Precision medicine, Nosology, Protein aggregation and Pathogenesis.
Much of his study explores Parkinson's disease relationship to Neurochemical.
In his work, Disease risk, Individual based, Lifestyle factors, Demography and Family history is strongly intertwined with Proportional hazards model, which is a subfield of Confidence interval.
His Amyotrophic lateral sclerosis research focuses on Neuroprotection and how it relates to Motor neuron, SOD1, Astrocyte and Antioxidant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
